Filing Details
- Accession Number:
- 0001127602-20-005685
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-14 16:49:58
- Reporting Period:
- 2020-02-12
- Accepted Time:
- 2020-02-14 16:49:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1492422 | Apellis Pharmaceuticals Inc. | APLS | Pharmaceutical Preparations (2834) | 271537290 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1657720 | Pascal Deschatelets | C/O Apellis Pharmaceuticals, Inc 100 Fifth Avenue, 3Rd Floor Waltham MA 02451 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-02-12 | 117,206 | $2.14 | 998,949 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-12 | 52,075 | $42.80 | 946,874 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-02-13 | 117,205 | $2.14 | 1,064,079 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-13 | 55,398 | $40.98 | 1,008,681 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-02-12 | 117,206 | $0.00 | 117,206 | $2.14 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-02-13 | 117,205 | $0.00 | 117,205 | $2.14 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 117,205 | 2020-05-12 | No | 4 | M | Direct | |
| 0 | 2020-05-12 | No | 4 | M | Direct |
Footnotes
- Open Market Sale to cover tax withholding for exercise.
- Average Sale Price within $1. Min $42.79-Max $43.14
- Average Sale Price within $1. Min $40.89-Max $41.59
- This is a scheduled exercise from 10B5-1 trading plan.
- This option was granted on May 12, 2010 and is fully vested.
Billionaire Hedge Funds
